Showing 381-390 of 4174 results for "".
- Analysis: Antiepileptic Drugs Linked to Nearly One-Quarter of Global SJS/TEN Caseshttps://practicaldermatology.com/news/antiepileptic-drugs-linked-to-nearly-one-quarter-of-global-sjsten-cases-meta-analysis-finds/2487988/Antiepileptic drugs (AEDs) account for nearly one-quarter of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cases reported worldwide, according to a systematic review and meta-analysis in JAMA Dermatology
- Study: Intentional Outdoor Tanning Common Among US Adults, Especially Young Womenhttps://practicaldermatology.com/news/intentional-outdoor-tanning-remains-common-among-us-adults-especially-young-women/2487924/Intentional outdoor tanning remains a common behavior among US adults, particularly younger women, according to a large cross-sectional analysis of nationally representative survey data published online in JAMA Dermatology.<
- Oral Vitamin D Associated With Faster Recovery From Cancer Therapy Skin Toxicitieshttps://practicaldermatology.com/news/oral-vitamin-d-associated-with-faster-recovery-from-cancer-therapy-skin-toxicities/2487854/High-dose oral vitamin D may offer a promising supportive care option for patients experiencing chemotherapy- and radiation-induced skin toxicities, according to a multicenter case series in JAMA Dermatology.
- Text Messaging Intervention Improves Cardiovascular Risk Behaviors in PsO Trialhttps://practicaldermatology.com/news/text-messaging-intervention-improves-cardiovascular-risk-behaviors-in-pso-trial/2487819/A structured text messaging intervention was shown to improve patient activation and several cardiovascular risk behaviors among adults with psoriasis, according to new findings published in JAMA Dermatology.
- High-Dose Vitamin D May Ease Chemotherapy- and Radiation-Related Skin Toxicities: Analysishttps://practicaldermatology.com/news/high-dose-vitamin-d-may-ease-chemotherapy-and-radiation-related-skin-toxicities/2487809/High-dose oral vitamin D may offer an option for patients experiencing chemotherapy- and radiation-induced skin toxicities, according to a multicenter case series published in JAMA Dermatology.
- New Data Support 24-Week Abrocitinib Tapering in Controlled ADhttps://practicaldermatology.com/news/new-data-support-24-week-abrocitinib-tapering-in-controlled-ad/2487773/New data published in the Journal of the American Academy of Dermatology suggests tapering abrocitinib may be a feasible strategy for patients with moderate-to-severe atopic dermatitis (AD) who have achieved an adequate clin
- Picankibart Shows Skin Clearance in Plaque Psoriasis: Analysishttps://practicaldermatology.com/news/picankibart-shows-skin-clearance-in-plaque-psoriasis/2487695/A phase III study published in the Journal of the American Academy of Dermatology found that picankibart, an investigational interleukin (IL)-23p19 inhibitor, produced high rates of skin clearance with durable efficacy throu
- Commentary Proposes Path to Cutting Plastic Waste in Dermatology Researchhttps://practicaldermatology.com/news/commentary-highlights-practical-route-to-cutting-plastic-waste-in-dermatology-research/2487685/The redesign of laboratory packaging to reduce plastic waste is a feasible near-term strategy for reducing plastic waste in skin-model research without disrupting validated experimental systems, according to a commentary in the Journal of Investigative Dermato
- Study Shows Racial Differences in Pseudofolliculitis Barbae Complications, Treatment Timinghttps://practicaldermatology.com/news/racial-differences-in-pfb-complications-treatment-timing-highlight-care-gaps/2487632/A multicenter retrospective cohort study published as a Letter to the Editor in the Journal of Drugs in Dermatology found that Black patients with pseudofolliculitis barbae (PFB) experienced significantly higher rates of post-inflammatory hyperpigmentation (PIH) and hypertrophic scarring
- Letter Questions Strength of Evidence Linking Hair Relaxers to Uterine Cancerhttps://practicaldermatology.com/news/letter-questions-strength-of-evidence-linking-hair-relaxers-to-uterine-cancer/2487618/A recently published Letter to the Editor in the Journal of Drugs in Dermatology urged clinicians to interpret the growing body of research examining chemical hair relaxers and uterine cancer with caution, arguing that important methodological limitations prevent current evidence from es